Diabetic Retinopathy Market segment
The Diabetic Retinopathy Market is segmented in several key ways to provide a detailed view of its structure and dynamics. By disease type, the market is divided into non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). NPDR holds the largest segment share due to its higher prevalence as the initial stage of the disease, but the PDR segment is poised for rapid growth as the number of diabetes patients with advanced-stage complications increases.
By treatment type, the market is categorized into anti-VEGF drugs, laser surgery, and vitrectomy. The anti-VEGF drug segment is the most dominant, driven by its effectiveness as a first-line treatment. Laser surgery and vitrectomy, while still widely used for specific cases, are considered for more advanced stages of the disease. By end-user, the market is segmented into hospitals, eye clinics, and ambulatory surgical centers. Hospitals and specialized eye clinics dominate the market due to the need for advanced diagnostic and surgical equipment. This granular segmentation is crucial for understanding the diverse needs of different market players and identifying key growth opportunities.